DEG-by-Index Ratio Transformation Normalization with Blood RNA-Seq Enhances Early and Consistent Detection of Mouse Tumorigenesis
Authors:
Open Access
Abstract
Variability in blood RNA-Seq data can obscure transcriptional changes that reflect tumor responses, and conventional normalization methods such as RLE/DESeq2 or TMM/edgeR often fail to capture these changes consistently. To address this challenge, we applied DiRT (DEG-by-index Ratio Transformation), a normalization and analysis strategy previously used in insect models, to 111 blood RNA-Seq datasets from mouse tumorigenesis models. DiRT achieved clearer separation between tumor and control samples as early as three days after tumor induction and maintained consistent marker signals across all stages of disease progression. In contrast, standard methods typically revealed differences only at later or scattered time points. KEGG pathway analysis further showed that DiRT-derived differentially expressed genes (DEGs) were enriched in the platelet activation signaling pathway, a pathway not identified using RLE/DESeq2 or TMM/edgeR. These findings demonstrate that DiRT enhances both sensitivity and reproducibility, enabling earlier and more consistent detection of transcriptional changes in blood during tumor development.Keywords
Funding Information
- National Research Foundation of Korea (2022H1D3A2A01053247)
- Korea Research Institute of Bioscience and Biotechnology (KGM1022511)
This publication has 32 references indexed in Scilit:
- Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and SpeciesImmunity, 2019
- Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolutionNature Communications, 2018
- Elements of cancer immunity and the cancer–immune set pointNature, 2017
- Translating RNA sequencing into clinical diagnostics: opportunities and challengesNature Reviews Genetics, 2016
- Platelets guide the formation of early metastatic nichesProceedings of the National Academy of Sciences, 2014
- The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancerInternational Journal of Cancer, 2014
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating ImmunosurveillanceImmunity, 2013
- Contribution of platelets to tumour metastasisNature Reviews Cancer, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Origin and physiological roles of inflammationNature, 2008